Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

Details 詳細情報について

• CRID

  1360580236997067904

• DOI

  10.1016/s2213-8587(22)00085-7

• ISSN

  22138587

• Web Site

  https://api.elsevier.com/content/article/PII:S2213858722000857?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S2213858722000857?httpAccept=text/plain

• Data Source

  • Crossref